| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/28/1992 | US5108989 Administering transfurming growth factor-beta prior to tissue damage |
| 04/28/1992 | US5108988 Hydrogenated derivatives of antibiotic a/16686 |
| 04/28/1992 | US5108987 Transferrin or ceruloplasmin linked with arabinoside cytosine methotrexate, vincristin, daunomycin, 6-mercaptopurine and cyclophosphamide |
| 04/28/1992 | US5108922 Wound healing agent, ability to induce the formation of bone and catilage; |
| 04/28/1992 | US5108911 Process for preparing bovine interleukin-Iβ |
| 04/28/1992 | US5108910 DNA sequences encoding fusion proteins comprising GM-CSF and IL-3 |
| 04/28/1992 | US5108901 Tissue plasminogen activator having zymogenic or fibrin specific properties |
| 04/28/1992 | US5108894 Recombinant dna having a nucleotide sequence coding for protein G or fragment thereof which is capable of specific bidning with immunoglobulins |
| 04/28/1992 | US5108754 Orthomolecular method of treating sickle cell disease |
| 04/28/1992 | US5108753 Osteogenic devices |
| 04/28/1992 | US5108746 Stabilizer composition and stabilized aqueous systems |
| 04/28/1992 | US5108745 Tuberculosis and legionellosis vaccines and methods for their production |
| 04/28/1992 | US5108744 Vaccines for Haemophilus influenzae |
| 04/28/1992 | US5108743 Administering polypeptide having human gamma interferon activity |
| 04/28/1992 | CA1299814C Mitogenic peptides |
| 04/28/1992 | CA1299752C Optical decoding technique for speech recognition |
| 04/28/1992 | CA1299508C Human pancreatic elastase i |
| 04/28/1992 | CA1299507C Grf analogs |
| 04/28/1992 | CA1299495C Pharmaceutical composition containing polypeptide |
| 04/27/1992 | WO1992007878A1 Neutralizing human monoclonal antibodies specific for the v3 loop and cd-4 binding site of hiv-1 gp120 |
| 04/27/1992 | CA2094713A1 Neutralizing human monoclonal antibodies specific for the v3 loop and cd-4 binding site of hiv-1 gp120 |
| 04/27/1992 | CA2054289A1 Smooth muscle mitogen |
| 04/27/1992 | CA2052988A1 Nutritional composition and a process for its production |
| 04/26/1992 | WO1992007873A1 Production and use of tracheal antimicrobial peptides |
| 04/26/1992 | CA2091760A1 Production and use of tracheal antimicrobial peptides |
| 04/25/1992 | CA2054097A1 Peptide compounds, processes for preparation thereof and pharmaceutical composition comprising the same |
| 04/24/1992 | WO1992006994A1 Identification of a suppressor of atherogenic apolipoprotein |
| 04/24/1992 | CA2093672A1 Identification of a suppressor of atherogenic apolipoprotein |
| 04/23/1992 | WO1992006709A1 Lipid a composition as immunogenic agents to prevent or treat gram-negative bacterial infections |
| 04/23/1992 | WO1992006693A1 Dna construct for providing rna therapy |
| 04/23/1992 | CA2094608A1 Dna construct for providing rna therapy |
| 04/23/1992 | CA2094588A1 Lipid a composition as immunogenic agents to prevent or treat gram-negative bacterial infections |
| 04/23/1992 | CA2053772A1 Benzolactam analogs as antagonists of cck |
| 04/22/1992 | EP0481970A2 Monoclonal antibodies against endotoxin of gram-negative bacteria |
| 04/22/1992 | EP0481899A1 Dietary drink for maintaining standing efforts |
| 04/22/1992 | EP0481790A2 Antibody production |
| 04/22/1992 | EP0481732A1 Prolonged release preparation and polymers thereof |
| 04/22/1992 | EP0481673A2 Genes encoding the human FK-506 binding protein and a S. cerevisiae homolog, FKB1, and their expression |
| 04/22/1992 | EP0481522A1 Novel mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| 04/22/1992 | EP0481311A2 Aminoacid derivatives |
| 04/22/1992 | EP0481207A1 Method for preventing or inhibiting loss of cognitive function employing a combination of an ace inhibitor and a drug that acts at serotonin receptors |
| 04/22/1992 | EP0481089A1 Human monoclonal antibody against glycoprotein gp iii of varicella zoster virus |
| 04/22/1992 | EP0481070A1 Multimeric gelsolin fusion constructs |
| 04/22/1992 | EP0481000A1 Receptors for fibroblast growth factors |
| 04/22/1992 | EP0480983A1 Use of peroxidated lipids for the preparation of medication to be used in the treatment, by local application, of circulation deficiencies. |
| 04/22/1992 | EP0480969A1 Amino acid analog cck antagonists |
| 04/22/1992 | EP0480918A1 Reduced size lhrh analogs |
| 04/22/1992 | EP0317573B1 Antipyretic and anti-inflammatory peptides |
| 04/22/1992 | EP0290471B1 Flour, bread, milk, and other products from white sweet potatoes, cassava, edible aroids, amaranth, yams, and lotus |
| 04/22/1992 | CN1060499A Human zona pellucida protein zp3 |
| 04/22/1992 | CN1060473A Fungicidally active compounds |
| 04/22/1992 | CN1060472A Tripeptide antithrombotic agents |
| 04/22/1992 | CN1016341B Novel spergualin-related compounds and process for producing the same |
| 04/21/1992 | US5106965 Detection of human adenovirus |
| 04/21/1992 | US5106956 Anticarcinogenic agents |
| 04/21/1992 | US5106954 Erythropoietin (epo) peptides |
| 04/21/1992 | US5106948 Anticarcinogenic agents |
| 04/21/1992 | US5106877 Including hydroxyalkyl hydrazines; preventing discoloration of teeth from antiplaque agents, food spoilage |
| 04/21/1992 | US5106836 Enteral diet |
| 04/21/1992 | US5106835 Renin inhibitors |
| 04/21/1992 | US5106834 Hypotensive agents |
| 04/21/1992 | US5106833 Coagulation inhibitors |
| 04/21/1992 | US5106832 Method for treating renal diseases |
| 04/21/1992 | US5106748 Isolated DNA molecule with sequence encoding bone morphogenic protein which induces formation of cartilage and/or bone |
| 04/21/1992 | US5106741 Tissue plasminogen activator (TPA) analogs |
| 04/21/1992 | US5106738 Exposing human lymphocyte to tumor cell antigen; immortalizing with transformation agent, Epstein-Barr virus |
| 04/21/1992 | US5106735 Cloning of a dna sequence encoding a sarcophaga peregrina antibacterial polypeptide precursor |
| 04/21/1992 | US5106733 Bovine granulocyte-macrophage colony stimulating factor |
| 04/21/1992 | US5106631 Cheese production |
| 04/21/1992 | US5106626 Proteins isolated from bones |
| 04/21/1992 | US5106621 Cysteine proteinases, production and use |
| 04/21/1992 | US5106618 Reducing number of oocysts, Cryptosporidia or Isospora parasites; for AIDS patients |
| 04/21/1992 | US5106617 Method of treating immature birds with IL-2 |
| 04/21/1992 | CA1299126C Hirudin-pa and its derivatives |
| 04/21/1992 | CA1299103C Method and compositions for increasing mammary parenchyma |
| 04/21/1992 | CA1299102C Insulin potentiation therapy |
| 04/20/1992 | CA2052014A1 Method for preventing diabetic complications employing a cholesterol lowering drug alone or in combination with an ace inhibitor |
| 04/19/1992 | WO1992007003A1 MODIFIED α2-MACROGLOBULINS AND THEIR USE AS SCAVENGERS FOR CYTOKINES AND GROWTH FACTORS |
| 04/19/1992 | WO1992006997A1 Peptide with activity of inhibiting phospholipase a2 originating in inflamed part |
| 04/19/1992 | WO1992006995A1 Preparation and characterization of liposomal formulations of tumor necrosis factor |
| 04/19/1992 | CA2091771A1 Preparation and characterization of liposomal formulations of tumor necrosis factor |
| 04/19/1992 | CA2071910A1 Peptide inhibitors of phospholipase a2 purified from inflammatory sites |
| 04/19/1992 | CA2070682A1 Modified.alpha.2-macroglobulins and their use as scavengers for cytokines and growth factors |
| 04/19/1992 | CA2053573A1 Amino acid derivatives |
| 04/18/1992 | WO1992006999A1 Therapeutic fragments of von willebrand factor |
| 04/18/1992 | WO1992006703A1 Synthetic lung surfactant |
| 04/18/1992 | CA2094259A1 Therapeutic fragments of von willebrand factor |
| 04/18/1992 | CA2053650A1 Endothelin precursors, genes and receptors |
| 04/16/1992 | WO1992006220A1 Detection and isolation of ligands |
| 04/16/1992 | WO1992006203A1 MUTANTS OF tPA WHICH ARE RESISTANT TO THEIR COGNATE SERPIN INHIBITOR |
| 04/16/1992 | WO1992006196A1 Gro genes, proteins, and uses thereof |
| 04/16/1992 | WO1992006195A1 Dna and amino acid sequence specific for natural killer cells and t cells |
| 04/16/1992 | WO1992006193A1 Antibodies directed against cd3 |
| 04/16/1992 | WO1992006191A1 Proteinaceous anti-dental plaque agents |
| 04/16/1992 | WO1992006190A1 Transgenic model for selective targeting of gene products with a megakaryocyte promoter |
| 04/16/1992 | WO1992006117A1 Inhibiting unwanted immune responses |
| 04/16/1992 | WO1992006114A1 Polypeptides derived from interleukin-1 beta, method for the preparation and utilisation thereof, particularly for osteoarticular pathologies |
| 04/16/1992 | WO1992006112A1 Activated ctap and analogs thereof and their use |
| 04/16/1992 | WO1992006111A1 Aprotinin analogues |
| 04/16/1992 | WO1992006109A1 Macrophage status modulation employing synthetic compounds |